{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T15:01:45Z","timestamp":1700665305132},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,4,4]],"date-time":"2007-04-04T00:00:00Z","timestamp":1175644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chronic hemodialysis patients are at higher risk for acquiring hepatitis C virus (HCV). The prevalence varies among different countries and hemodialysis centers. Although guidelines for a comprehensive infection control program exist, the nosocomial transmission still accounts for the new cases of infection. The aim of this study was analyze the follow up of newly acquired acute hepatitis C cases, during the period from January 2002 to May 2005, in the Hemodialysis Center, located in the Southwest region of Parana State, Brazil and to analyze the effectiveness of the measures to restrain the appearance of new cases of acute hepatitis C.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients were analyzed monthly with anti-HCV tests and ALT measurements. Patients with ALT elevations were monitored for possible acute hepatitis C.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>During this period, 32 new cases were identified with acute hepatitis C virus infection. Blood screening showed variable ALT levels preceding the anti-HCV seroconversion. HCV RNA viremia by PCR analysis was intermittently and even negative in some cases. Ten out of 32 patients received 1 mcg\/kg dose of pegylated interferon alfa-2b treatment for 24 weeks. All dialysis personnel were re-trained to strictly follow the regulations and recommendations regarding infection control, proper methods to clean and disinfect equipment were reviewed and HCV-positive patients were isolated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Laboratory tests results showed variable ALT preceding anti-HCV seroconversion and intermittent viremia. The applied recommendations contributed importantly to restrain the appearance of new cases of acute hepatitis C in this center and the last case was diagnosed in May 2004.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2458-7-50","type":"journal-article","created":{"date-parts":[[2007,5,2]],"date-time":"2007-05-02T15:33:22Z","timestamp":1178120002000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil"],"prefix":"10.1186","volume":"7","author":[{"given":"Maricea","family":"Engel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda M","family":"Malta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele MS","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel MVGC","family":"Mello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o RR","family":"Pinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzane K","family":"Ono-Nita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flair J","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,4]]},"reference":[{"issue":"2","key":"661_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.antiviral.2003.08.008","volume":"60","author":"G Barril","year":"2003","unstructured":"Barril G, Traver JA: Decrease in the hepatitis C virus (HCV) prevalence in hemodialysis patients in Spain: effect of time, initiating HCV prevalence studies and adoption of isolation measures. Antiviral Res. 2003, 60 (2): 129-134. 10.1016\/j.antiviral.2003.08.008.","journal-title":"Antiviral Res"},{"issue":"2","key":"661_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/ndt\/12.2.304","volume":"12","author":"KJ McLaughlin","year":"1997","unstructured":"McLaughlin KJ, Cameron SO, Good T, McCruden E, Ferguson JC, Davidson F, Simmonds P, Mactier RA, McMillan MA: Nosocomial transmission of hepatitis C virus within a British dialysis centre. Nephrol Dial Transplant. 1997, 12 (2): 304-309. 10.1093\/ndt\/12.2.304.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"661_CR3","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/oxfordjournals.ndt.a027090","volume":"11","author":"JP dos Santos","year":"1996","unstructured":"dos Santos JP, Loureiro A, Cendoroglo Neto M, Pereira BJ: Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units. Nephrol Dial Transplant. 1996, 11 (10): 2017-2022.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"661_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1157\/13075954","volume":"19","author":"J Castell","year":"2005","unstructured":"Castell J, Gutierrez G: [Outbreak of 18 cases of hepatitis C in a hemodialysis unit]. Gac Sanit. 2005, 19 (3): 214-220. 10.1157\/13075954.","journal-title":"Gac Sanit"},{"issue":"6","key":"661_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1086\/502060","volume":"23","author":"E Delarocque-Astagneau","year":"2002","unstructured":"Delarocque-Astagneau E, Baffoy N, Thiers V, Simon N, de Valk H, Laperche S, Courouce AM, Astagneau P, Buisson C, Desenclos JC: Outbreak of hepatitis C virus infection in a hemodialysis unit: potential transmission by the hemodialysis machine?. Infect Control Hosp Epidemiol. 2002, 23 (6): 328-334. 10.1086\/502060.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"661_CR6","unstructured":"Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001, 50 (RR-5): 1-43."},{"issue":"1","key":"661_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0272-6386(00)70310-6","volume":"35","author":"F Fabrizi","year":"2000","unstructured":"Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Vinson S, Mousa M, Gitnick G: Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis. 2000, 35 (1): 122-129.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"661_CR8","first-page":"467","volume":"16","author":"F Fabrizi","year":"2003","unstructured":"Fabrizi F, Bunnapradist S, Lunghi G, Martin P: Kinetics of hepatitis C virus load during hemodialysis: novel perspectives. J Nephrol. 2003, 16 (4): 467-475.","journal-title":"J Nephrol"},{"issue":"5","key":"661_CR9","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/ndt\/13.5.1211","volume":"13","author":"F Galan","year":"1998","unstructured":"Galan F, Perez-Gracia MT, Lozano A, Benavides B, Fernandez-Ruiz E, Rodriguez-Iglesias MA: A 3-year follow-up of HCV-RNA viraemia in haemodialysis patients. Nephrol Dial Transplant. 1998, 13 (5): 1211-1214. 10.1093\/ndt\/13.5.1211.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"661_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1159\/000188520","volume":"69","author":"JY Guh","year":"1995","unstructured":"Guh JY, Lai YH, Yang CY, Chen SC, Chuang WL, Hsu TC, Chen HC, Chang WY, Tsai JH: Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron. 1995, 69 (4): 459-465.","journal-title":"Nephron"},{"issue":"2","key":"661_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1053\/ajkd.2001.21294","volume":"37","author":"S Saab","year":"2001","unstructured":"Saab S, Martin P, Brezina M, Gitnick G, Yee HF: Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis. Am J Kidney Dis. 2001, 37 (2): 308-315.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"661_CR12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/0016-5085(95)90591-X","volume":"109","author":"K Yasuda","year":"1995","unstructured":"Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y: Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology. 1995, 109 (4): 1295-1300. 10.1016\/0016-5085(95)90591-X.","journal-title":"Gastroenterology"},{"issue":"1","key":"661_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987, 162 (1): 156-159. 10.1016\/0003-2697(87)90021-2.","journal-title":"Anal Biochem"},{"issue":"1","key":"661_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1590\/S0100-879X2005000100007","volume":"38","author":"S Campiotto","year":"2005","unstructured":"Campiotto S, Pinho JR, Carrilho FJ, Da Silva LC, Souto FJ, Spinelli V, Pereira LM, Coelho HS, Silva AO, Fonseca JC, Rosa H, Lacet CM, Bernardini AP: Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res. 2005, 38 (1): 41-49. 10.1590\/S0100-879X2005000100007.","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"661_CR15","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1523-1755.1998.00823.x","volume":"53","author":"M Jadoul","year":"1998","unstructured":"Jadoul M, Cornu C, van Ypersele de Strihou C: Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int. 1998, 53 (4): 1022-1025. 10.1111\/j.1523-1755.1998.00823.x.","journal-title":"Kidney Int"},{"issue":"5","key":"661_CR16","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S0272-6386(05)80017-4","volume":"37","author":"N Petrosillo","year":"2001","unstructured":"Petrosillo N, Gilli P, Serraino D, Dentico P, Mele A, Ragni P, Puro V, Casalino C, Ippolito G: Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis. 2001, 37 (5): 1004-1010.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"661_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00002480-199801000-00019","volume":"44","author":"JI Tokars","year":"1998","unstructured":"Tokars JI, Miller ER, Alter MJ, Arduino MJ: National surveillance of dialysis associated diseases in the United States, 1995. Asaio J. 1998, 44 (1): 98-107. 10.1097\/00002480-199801000-00019.","journal-title":"Asaio J"},{"key":"661_CR18","volume-title":"Estabelece o Regulamento T\u00e9cnico para o Funcionamento dos Servi\u00e7os de Di\u00e1lise","author":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria - ANVISA","year":"2004","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria - ANVISA: Estabelece o Regulamento T\u00e9cnico para o Funcionamento dos Servi\u00e7os de Di\u00e1lise. 2004, D.O.U. - Di\u00e1rio Oficial da Uni\u00e3o, 154:"},{"key":"661_CR19","doi-asserted-by":"crossref","unstructured":"National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002. Hepatology. 2002, 36 (5 Suppl 1): S3-20.","DOI":"10.1053\/jhep.2002.37117"},{"issue":"1","key":"661_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1590\/S0037-86822004000100005","volume":"37","author":"EC Gouveia","year":"2004","unstructured":"Gouveia EC, Lopes EP, Moura I, Cruz M, Kosminsky L, Pernambuco JR: [Identification of the cutoff value for serum alanine aminotransferase in hepatitis C screening of patients with chronic renal failure on hemodialysis]. Rev Soc Bras Med Trop. 2004, 37 (1): 18-21.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"4","key":"661_CR21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/snep.2002.33674","volume":"22","author":"S Pol","year":"2002","unstructured":"Pol S, Vallet-Pichard A, Fontaine H, Lebray P: HCV infection and hemodialysis. Semin Nephrol. 2002, 22 (4): 331-339.","journal-title":"Semin Nephrol"},{"issue":"1","key":"661_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1046\/j.1365-2893.2001.00268.x","volume":"8","author":"M Gursoy","year":"2001","unstructured":"Gursoy M, Gur G, Arslan H, Ozdemir N, Boyacioglu S: Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment. J Viral Hepat. 2001, 8 (1): 70-77. 10.1046\/j.1365-2893.2001.00268.x.","journal-title":"J Viral Hepat"},{"issue":"4","key":"661_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000079871","volume":"22","author":"P Urbanek","year":"2004","unstructured":"Urbanek P, Tesar V, Prochazkova-Francisci E, Lachmanova J, Marecek Z, Svobodnik A: Treatment of early diagnosed HCV infection in hemodialyzed patients with interferon-alpha. Treatment of hepatitis C. Blood Purif. 2004, 22 (4): 344-350. 10.1159\/000079871.","journal-title":"Blood Purif"},{"issue":"3","key":"661_CR24","first-page":"220","volume":"55","author":"M Espinosa","year":"2001","unstructured":"Espinosa M, Rodriguez M, Martin-Malo A, Alvarez de Lara MA, Gonzalez R, Lopez-Rubio F, de la Mata M, Aljama P: Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response. Clin Nephrol. 2001, 55 (3): 220-226.","journal-title":"Clin Nephrol"},{"issue":"5","key":"661_CR25","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/hep.20196","volume":"39","author":"H Nomura","year":"2004","unstructured":"Nomura H, Sou S, Tanimoto H, Nagahama T, Kimura Y, Hayashi J, Ishibashi H, Kashiwagi S: Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial. Hepatology. 2004, 39 (5): 1213-1219. 10.1002\/hep.20196.","journal-title":"Hepatology"},{"issue":"8","key":"661_CR26","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1365-2036.2004.02170.x","volume":"20","author":"GR Foster","year":"2004","unstructured":"Foster GR: Review article: pegylated interferons: chemical and clinical differences. Aliment Pharmacol Ther. 2004, 20 (8): 825-830. 10.1111\/j.1365-2036.2004.02170.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"661_CR27","first-page":"79","volume":"102","author":"CS Yang","year":"2003","unstructured":"Yang CS, Chang HH, Chou CC, Peng SJ: Isolation effectively prevents the transmission of hepatitis C virus in the hemodialysis unit. J Formos Med Assoc. 2003, 102 (2): 79-85.","journal-title":"J Formos Med Assoc"},{"issue":"7","key":"661_CR28","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/jcm.34.7.1633-1636.1996","volume":"34","author":"FH Pujol","year":"1996","unstructured":"Pujol FH, Ponce JG, Lema MG, Capriles F, Devesa M, Sirit F, Salazar M, Vasquez G, Monsalve F, Blitz-Dorfman L: High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. J Clin Microbiol. 1996, 34 (7): 1633-1636.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-7-50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-7-50\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-7-50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-7-50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T09:40:05Z","timestamp":1630489205000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-7-50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["661"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-7-50","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,4]]},"assertion":[{"value":"28 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"50"}}